NCCN  	NCCN  	 NNP	B-NP
molecular  	molecular  	 VBZ	I-NP
testing  	testing  	 VBG	O
white  	white  	 JJ	O
paper 	paper 	 NN	O
:  	:  	 :	O
effectiveness 	effectiveness 	 NN	O
,  	,  	 ,	O
efficiency 	efficiency 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
reimbursement  	reimbursement  	 JJ	B-NP
Personalized  	Personalized  	 JJ	I-NP
medicine  	medicine  	 NN	I-NP
in  	in  	 IN	O
oncology  	oncology  	 NN	B-NP
is  	is  	 VBZ	O
maturing  	maturing  	 VBG	O
and  	and  	 CC	O
evolving  	evolving  	 VBG	O
rapidly 	rapidly 	 RB	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
molecular  	molecular  	 JJ	B-NP
biomarkers  	biomarkers  	 NN	I-NP
in  	in  	 IN	O
clinical  	clinical  	 JJ	B-NP
decision-making  	decision-making  	 NN	I-NP
is  	is  	 VBZ	O
growing 	growing 	 VBG	O
.  	.  	 .	O
This  	This  	 DT	O
raises  	raises  	 VBZ	O
important  	important  	 JJ	O
issues  	issues  	 NNS	O
regarding  	regarding  	 VBG	O
the  	the  	 DT	O
safe 	safe 	 JJ	O
,  	,  	 ,	O
effective 	effective 	 JJ	O
,  	,  	 ,	O
and  	and  	 CC	O
efficient  	efficient  	 JJ	O
deployment  	deployment  	 NN	O
of  	of  	 IN	O
molecular  	molecular  	 JJ	B-NP
tests  	tests  	 NNS	I-NP
to  	to  	 TO	O
guide  	guide  	 VB	O
appropriate  	appropriate  	 JJ	O
care 	care 	 NN	O
,  	,  	 ,	O
specifically  	specifically  	 RB	O
regarding  	regarding  	 VBG	O
laboratory-developed  	laboratory-developed  	 JJ	O
tests  	tests  	 NNS	O
and  	and  	 CC	O
companion  	companion  	 NN	B-NP
diagnostics 	diagnostics 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
May  	May  	 NNP	O
2011 	2011 	 CD	O
,  	,  	 ,	O
NCCN  	NCCN  	 NNP	B-NP
assembled  	assembled  	 VBD	O
a  	a  	 DT	O
work  	work  	 NN	B-NP
group  	group  	 NN	I-NP
composed  	composed  	 VBN	O
of  	of  	 IN	O
thought  	thought  	 NN	B-NP
leaders  	leaders  	 NNS	I-NP
from  	from  	 IN	O
NCCN  	NCCN  	 NNP	B-NP
Member  	Member  	 NNP	I-NP
Institutions  	Institutions  	 NNPS	I-NP
and  	and  	 CC	O
other  	other  	 JJ	O
organizations  	organizations  	 NNS	B-NP
to  	to  	 TO	O
identify  	identify  	 VB	O
challenges  	challenges  	 NNS	O
and  	and  	 CC	O
provide  	provide  	 VB	O
guidance  	guidance  	 VBN	O
regarding  	regarding  	 VBG	O
molecular  	molecular  	 JJ	B-NP
testing  	testing  	 NN	I-NP
in  	in  	 IN	O
oncology  	oncology  	 NN	B-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
corresponding  	corresponding  	 JJ	O
utility  	utility  	 NN	O
from  	from  	 IN	O
clinical 	clinical 	 JJ	O
,  	,  	 ,	O
scientific 	scientific 	 JJ	O
,  	,  	 ,	O
and  	and  	 CC	O
coverage  	coverage  	 NN	B-NP
policy  	policy  	 NN	I-NP
standpoints 	standpoints 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
NCCN  	NCCN  	 NNP	B-NP
Molecular  	Molecular  	 NNP	I-NP
Testing  	Testing  	 NNP	O
Work  	Work  	 NNP	O
Group  	Group  	 NNP	O
identified  	identified  	 VBD	B-NP
challenges  	challenges  	 NNS	I-NP
surrounding  	surrounding  	 VBG	O
molecular  	molecular  	 JJ	B-NP
testing 	testing 	 NN	I-NP
,  	,  	 ,	O
including  	including  	 VBG	B-NP
health  	health  	 NN	I-NP
care  	care  	 NN	I-NP
provider  	provider  	 NN	I-NP
knowledge 	knowledge 	 NN	I-NP
,  	,  	 ,	O
determining  	determining  	 VBG	O
clinical  	clinical  	 JJ	B-NP
utility 	utility 	 NN	I-NP
,  	,  	 ,	O
coding  	coding  	 NN	O
and  	and  	 CC	O
billing  	billing  	 NN	O
for  	for  	 IN	O
molecular  	molecular  	 JJ	B-NP
tests 	tests 	 NNS	I-NP
,  	,  	 ,	O
maintaining  	maintaining  	 VBG	O
clinical  	clinical  	 JJ	O
and  	and  	 CC	O
analytic  	analytic  	 JJ	B-NP
validity  	validity  	 NN	I-NP
of  	of  	 IN	I-NP
molecular  	molecular  	 JJ	I-NP
tests 	tests 	 NNS	I-NP
,  	,  	 ,	O
efficient  	efficient  	 JJ	O
use  	use  	 NN	O
of  	of  	 IN	O
specimens 	specimens 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
building  	building  	 VBG	O
clinical  	clinical  	 JJ	B-NP
evidence 	evidence 	 NN	I-NP
.  	.  	 .	O
